Recombinant Protein DT3C

Recombinant Protein DT3C

Known as Diphtheria Toxin Fragment A-Diphtheria Toxin Fragment C (DTA-DTC), has several applications primarily due to its ability to selectively kill cells expressing specific surface markers.


Modular Structure

DT3C is a fusion protein consisting of Diphtheria Toxin Fragment A (DTA) linked to Diphtheria Toxin Fragment C (DTC). 

Potent Cytotoxic Activity

DTA, the enzymatic domain of DT3C, possesses potent cytotoxic activity by inhibiting protein synthesis in cells


Selective Cytotoxicity

DT3C exhibits selective cytotoxicity towards cells expressing specific surface markers or antigens. 


Targeted Cell Ablation:

T3C can be used for targeted cell ablation in cell culture systems, animal models, and potentially in clinical settings.

Creation of Knockout Animal


DT3C can be used to generate knockout animal models by selectively ablating cells expressing a particular gene of interest

Cancer Therapy

DT3C has potential applications in cancer therapy, particularly in targeted cancer treatment strategies


Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.
Potential Therapeutic Applications of Recombinant Marmota monax Tumor Necrosis Factor (TNF) in Sickle Cell Disease